ArticleOncogene2016

Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.

R Gopalakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.